New Treatment Approved for Acute Myeloid Leukemia

The combination chemotherapy drug Vyxeos (daunorubicin and cytarabine) has been approved by the U.S. Food and Drug Administration as the first treatment for certain high-risk types of acute myeloid leukemia (AML).

Mental Health Does Not Come With A Manual, It Comes With Friends & Family Support That Never Gives Up!
Join now

AML is an aggressive blood cancer that forms in the bone marrow.

"Vyxeos combines two commonly used chemotherapies into a single formulation that may help some patients live longer than if they were to receive the two therapies separately," said Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence.

In a news release Thursday, the agency said more than 21,000 people will be diagnosed this year with AML, and more than 10,000 will die from it, according to projections from the U.S. National Cancer Institute.

The new therapy is sanctioned for high-risk forms of newly-diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). People with either disease have a very low life expectancy, the FDA said.

Vyxeos was evaluated in clinical trials involving 309 people with either form of AML. Those given Vyxeos lived an average of 9.6 months, compared with 5.9 months among those who took an inactive placebo.

The therapy's most common side effects included bleeding, fever, low white blood-cell count, rash, tissue swelling and nausea. Some users had episodes of serious allergic-like hypersensitivity reactions or dangerous bleeding, the agency said.

Women who are pregnant or breast-feeding shouldn't take Vyxeos, the FDA added.

The Internet's Most Trusted Source For Mental Health Information
Sign up

Approval of the drug was granted to the Irish firm Jazz Pharmaceuticals.

More information

To learn more about this approval, visit the FDA.


Copyright © 2013-2017 HealthDay. All rights reserved.


Related Content

What If Your Anxiety & Depression Is Really A Sign Of ADHD?
What If Your Anxiety & Depression Is Really A Sign Of ADHD?

More often than not, when a person over the age of 10 is diagnosed with attentio...

Read more
New Patent By OxyContin Maker May Treat Pain But Comes With Addictive Potential
New Patent By OxyContin Maker May Treat Pain But Comes With Addictive Potential

Purdue Pharma, the maker of OxyContin, has received a patent designed to treat o...

Read more
Why Are Transgenders Experiencing More Mental Health Issues Than The General Public?
Why Are Transgenders Experiencing More Mental Health Issues Than The General Public?

Individuals who identify as transgender tend to experience higher rates of menta...

Read more
New Research In Schizophrenia Shows That A Video Game Can Aid In Preventing Hallucinations
New Research In Schizophrenia Shows That A Video Game Can Aid In Preventing Hallucinations

People with schizophrenia can be trained by playing a video game to control the ...

Read more
I was 12 When I Survived 9-11 But My Peers & I Are Only Now Realizing Our PTSD
I was 12 When I Survived 9-11 But My Peers & I Are Only Now Realizing Our PTSD

As the Twin Towers burned and eventually collapsed on 9/11, I was running from m...

Read more
How Running Helped These Everyday People Beat OCD, Depression & Anxiety
How Running Helped These Everyday People Beat OCD, Depression & Anxiety

When documentary photographer Martin Eberlen was diagnosed with ADHD in his earl...

Read more